cd123 Search Results


cd123 mab  (Miltenyi Biotec)
95
Miltenyi Biotec cd123 mab
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Cd123 Mab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd123 mab/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd123 mab - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
recombinant human cd123 protein  (R&D Systems)
93
R&D Systems recombinant human cd123 protein
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Recombinant Human Cd123 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human cd123 protein/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant human cd123 protein - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
apc conjugated anti cd123  (Miltenyi Biotec)
93
Miltenyi Biotec apc conjugated anti cd123
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Apc Conjugated Anti Cd123, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc conjugated anti cd123/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
apc conjugated anti cd123 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cd123 pe cy5  (Miltenyi Biotec)
94
Miltenyi Biotec cd123 pe cy5
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Cd123 Pe Cy5, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd123 pe cy5/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd123 pe cy5 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti cd123  (Miltenyi Biotec)
95
Miltenyi Biotec anti cd123
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Anti Cd123, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd123/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd123 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd123  (Miltenyi Biotec)
95
Miltenyi Biotec cd123
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Cd123, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd123/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd123 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd123  (R&D Systems)
92
R&D Systems cd123
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Cd123, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd123/product/R&D Systems
Average 92 stars, based on 1 article reviews
cd123 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
cd123 6h6 fluidigm 3151001b 152sm tcrgd b1 fluidigm 3152008b 153sm cd45ra hi100 fluidigm 3153001b  (fluidigm)
95
fluidigm cd123 6h6 fluidigm 3151001b 152sm tcrgd b1 fluidigm 3152008b 153sm cd45ra hi100 fluidigm 3153001b
Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, <t>CD123,</t> or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.
Cd123 6h6 Fluidigm 3151001b 152sm Tcrgd B1 Fluidigm 3152008b 153sm Cd45ra Hi100 Fluidigm 3153001b, supplied by fluidigm, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd123 6h6 fluidigm 3151001b 152sm tcrgd b1 fluidigm 3152008b 153sm cd45ra hi100 fluidigm 3153001b/product/fluidigm
Average 95 stars, based on 1 article reviews
cd123 6h6 fluidigm 3151001b 152sm tcrgd b1 fluidigm 3152008b 153sm cd45ra hi100 fluidigm 3153001b - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
mouse monoclonal anti human cd123  (fluidigm)
93
fluidigm mouse monoclonal anti human cd123

Mouse Monoclonal Anti Human Cd123, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti human cd123/product/fluidigm
Average 93 stars, based on 1 article reviews
mouse monoclonal anti human cd123 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
biotinylated human cd123  (R&D Systems)
94
R&D Systems biotinylated human cd123

Biotinylated Human Cd123, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated human cd123/product/R&D Systems
Average 94 stars, based on 1 article reviews
biotinylated human cd123 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti cd123 apc  (Miltenyi Biotec)
95
Miltenyi Biotec anti cd123 apc

Anti Cd123 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd123 apc/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd123 apc - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, CD123, or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.

Journal: The Journal of Biological Chemistry

Article Title: Human CD300C Delivers an Fc Receptor-?-dependent Activating Signal in Mast Cells and Monocytes and Differs from CD300A in Ligand Recognition *

doi: 10.1074/jbc.M112.434746

Figure Lengend Snippet: Cell surface expression of CD300A and CD300C in human hematopoietic cells. A, analysis of CD300A or CD300C expression in hematopoietic cells derived from human PB. FSChighSSChigh populations in neutrophils or eosinophils or FSClow/intSSClow/int populations in basophils, T cells, B cells, monocytes, NK cells, or PDCs were gated. The cells were stained with FITC-conjugated anti-CD3, CD19, CD56, BDCA-2, CD123, or CD16 mAb or allophycocyanin-conjugated anti-CD14 mAb and analyzed for CD300A or CD300C expression. B, human PB-derived Mφ-1 or Mφ-2 were stained with R-PE-conjugated anti-CD11b, CD14, or HLR-DR mAb or FITC-conjugated CD11c mAb and were analyzed for CD300A or CD300C expression. C, human monocyte-derived DCs were cultured for 24 h in the presence or absence of 1 ng/ml LPS or 10 ng/ml TNFα. The cells were stained with R-PE-conjugated anti-CD80, CD83, or CD86 mAb and were analyzed for CD300A or CD300C expression. D, human PB-derived mast cells were analyzed for CD300A or CD300C expression. The results of control staining are shown as filled histograms. All of the data are representative of three independent experiments.

Article Snippet: R-PE-conjugated anti-human blood dendritic cell antigen-2 mAb and FITC-conjugated CD16 or CD123 mAb were from Miltenyi Biotech.

Techniques: Expressing, Derivative Assay, Staining, Cell Culture, Control

Journal: eLife

Article Title: JAK inhibition decreases the autoimmune burden in Down syndrome

doi: 10.7554/eLife.99323

Figure Lengend Snippet:

Article Snippet: Antibody , Mouse monoclonal anti-human CD123 (clone 6 H6) , Fluidigm , Cat # 3143014B; RRID: AB_2811081 , Lot 3431917, 1:100.

Techniques: Isolation, Biomarker Discovery, Staining, Antibody Labeling, Software, Sequencing